Cargando…

Combining Gene Signatures Improves Prediction of Breast Cancer Survival

BACKGROUND: Several gene sets for prediction of breast cancer survival have been derived from whole-genome mRNA expression profiles. Here, we develop a statistical framework to explore whether combination of the information from such sets may improve prediction of recurrence and breast cancer specif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xi, Rødland, Einar Andreas, Sørlie, Therese, Naume, Bjørn, Langerød, Anita, Frigessi, Arnoldo, Kristensen, Vessela N., Børresen-Dale, Anne-Lise, Lingjærde, Ole Christian
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053398/ https://www.ncbi.nlm.nih.gov/pubmed/21423775 http://dx.doi.org/10.1371/journal.pone.0017845

Ejemplares similares

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
por: Zhao, Xi, et al.
Publicado: (2014)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

DNA copy number motifs are strong and independent predictors of survival in breast cancer
por: Pladsen, Arne V., et al.
Publicado: (2020)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancers
por: Castro-Mondragon, Jaime A, et al.
Publicado: (2022)

In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome
por: Myhre, Simen, et al.
Publicado: (2010)

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
por: Sørlie, Therese, et al.
Publicado: (2006)

Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

DNA methylation at enhancers identifies distinct breast cancer lineages
por: Fleischer, Thomas, et al.
Publicado: (2017)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2015)

Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006)

Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
por: Haugen, Mads H., et al.
Publicado: (2021)

Merging transcriptomics and metabolomics - advances in breast cancer profiling
por: Borgan, Eldrid, et al.
Publicado: (2010)

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2011)

Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2013)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016)

Multilocus analysis of SNP and metabolic data within a given pathway
por: Kristensen, Vessela N, et al.
Publicado: (2006)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019)

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
por: Aure, Miriam Ragle, et al.
Publicado: (2017)

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
por: Chanock, Stephen J, et al.
Publicado: (2007)

Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study
por: Dumeaux, Vanessa, et al.
Publicado: (2008)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Transcriptomic pan‐cancer analysis using rank‐based Bayesian inference
por: Vitelli, Valeria, et al.
Publicado: (2023)

Long Non-Coding RNAs Differentially Expressed between Normal versus Primary Breast Tumor Tissues Disclose Converse Changes to Breast Cancer-Related Protein-Coding Genes
por: Reiche, Kristin, et al.
Publicado: (2014)

Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN
por: Borge, Kaja S., et al.
Publicado: (2015)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2015)

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
por: Engebraaten, Olav, et al.
Publicado: (2012)

Allele-specific disparity in breast cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2011)

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases
por: Østrup, Olga, et al.
Publicado: (2017)

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
por: Höglander, Elen Kristine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tgkvsqfobh99j660sudqv886gc